Home » Reckitt Benckiser Pharmaceuticals Announces SFDA Approval of New Dosage Strengths of Suboxone Sublingual Film
Reckitt Benckiser Pharmaceuticals Announces SFDA Approval of New Dosage Strengths of Suboxone Sublingual Film
Reckitt Benckiser Pharmaceuticals announced the FDA approval of the 4-mg and 12-mg doses of Suboxone (buprenorphine and naloxone) sublingual film.
The Sacramento Bee
The Sacramento Bee
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May